Alkermes Announces Priority Review By FDA For VIVITROL(R) For Opioid Dependence
Links shared publicly online about this topic.
- 1,138total visits
Alkermes Announces Priority Review By FDA For VIVITROL(R) For Opioid Dependence
View full resource at medicalnewstoday.com
Tags: Addiction, Substance Addiction, Drug, FDA
Most Recently Shared on May 27, 2010 at 2:11 pm By:
Alkermes Announces Priority Review By FDA For VIVITROL(R) For Opioid Dependence http://mnt.to/3D8x #regulatory
Also Shared By:
FDA grants priority review to Vivitrol for opioid dependence - ONA
oncologynurseadvisor.com — “Alkermes announced that the supplemental New Drug Application (sNDA) for Vivitrol (naltrexone for extended-release injectable suspension) for opioid dependence has been granted priority review by the FDA.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 25, 2010 at 8:42 pm By:
OncologyNurseAdvisor Nursing, Medical Education, Medical Publisher, and Oncology
FDA grants priority review to Vivitrol for opioid dependence http://goo.gl/fb/icIQU
FDA grants priority review to Vivitrol for opioid dependence - MPR
empr.com — “Alkermes announced that the supplemental New Drug Application (sNDA) for Vivitrol (naltrexone for extended-release injectable suspension) for opioid dependence has been granted priority review by the FDA.” View full resource at empr.com
Most Recently Shared on May 25, 2010 at 4:44 pm By:
FDA grants priority review to Vivitrol for opioid dependence: Alkermes announced that the supplemental New Drug Ap... http://bit.ly/bdN3HW
Advertisement
MNT Alcohol / Addict
@mnt_alcoholadd
Alkermes Announces Priority Review By FDA For VIVITROL(R) For Opioid Dependence http://mnt.to/3D8x #alcohol #addiction
1 year ago...